Christopher Brynczka

458 total citations
8 papers, 290 citations indexed

About

Christopher Brynczka is a scholar working on Molecular Biology, Oncology and Hepatology. According to data from OpenAlex, Christopher Brynczka has authored 8 papers receiving a total of 290 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Oncology and 2 papers in Hepatology. Recurrent topics in Christopher Brynczka's work include Cancer-related Molecular Pathways (3 papers), Cancer-related gene regulation (3 papers) and Biochemical and Molecular Research (2 papers). Christopher Brynczka is often cited by papers focused on Cancer-related Molecular Pathways (3 papers), Cancer-related gene regulation (3 papers) and Biochemical and Molecular Research (2 papers). Christopher Brynczka collaborates with scholars based in United States, China and France. Christopher Brynczka's co-authors include B. Alex Merrick, Paul Labhart, Aileen M. Healy, Roger Rush, Peter W. Vanderklish, Matthew J. Shumway, Alexia M. Thomas, Lasani S. Wijetunge, Rebecca Hammond and Mark F. Bear and has published in prestigious journals such as Scientific Reports, Science Translational Medicine and Toxicological Sciences.

In The Last Decade

Christopher Brynczka

8 papers receiving 288 citations

Peers

Countries citing papers authored by Christopher Brynczka

Since Specialization

Citations

This map shows the geographic impact of Christopher Brynczka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Brynczka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Brynczka more than expected).

Fields of papers citing papers by Christopher Brynczka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Brynczka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Brynczka. The network helps show where Christopher Brynczka may publish in the future.

Co-authorship network of co-authors of Christopher Brynczka

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Brynczka. A scholar is included among the top collaborators of Christopher Brynczka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Brynczka. Christopher Brynczka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

#	Work	Indexed citations
1	Abstract B074: Discovery of MK-1084, a low dose selective clinical stage KRAS G12C inhibitor 2023 ·Molecular Cancer Therapeutics ·Matthew L. Maddess, David L. Sloman, Xiaoshen Ma, Anandan Palani, Alexander Stoeck, Aaron C. Sather, Nicolas Solban, Ruchia Duggal, Jeanine Ballard, (unknown), Lin‐Chi Chen, Yongxin Han, Richard Miller, Symon Gathiaka, Christopher Brynczka, Hongming Li, Ruojing Yang, (unknown)	1
2	Polyethlyene Glycol 200 Can Protect Rats Against Drug-Induced Kidney Toxicity Through Inhibition of the Renal Organic Anion Transporter 3 2019 ·Toxicological Sciences ·(unknown), Xiaoyan Chu, Robert Houle, Kateřina Vlasáková, Kenneth A. Koeplinger, Isabelle Bourgeois, Kiran Palyada, Kenneth D. Anderson, Christopher Brynczka, (unknown), Feifei Chen, Roger Smith, Rupesh P. Amin, Warren E. Glaab, José Antonio Lebrón, Kathleen Cox, Frank D. Sistare	2
3	Cardiac drug-drug interaction between HCV-NS5B pronucleotide inhibitors and amiodarone is determined by their specific diastereochemistry 2017 ·Scientific Reports ·Armando Lagrutta, Christopher P. Regan, Haoyu Zeng, John P. Imredy, Kenneth A. Koeplinger, Pierre Morissette, Liping Liu, Gordon K. Wollenberg, Christopher Brynczka, José Antonio Lebrón, Joseph J. DeGeorge, Frederick Sannajust	13
4	TLE4 regulation of wnt-mediated inflammation underlies its role as a tumor suppressor in myeloid leukemia 2016 ·Leukemia Research ·(unknown), Christopher Brynczka, Farshid Dayyani, Miguel N. Rivera, David A. Sweetser	12
5	Reversal of Disease-Related Pathologies in the Fragile X Mouse Model by Selective Activation of GABA_BReceptors with Arbaclofen 2012 ·Science Translational Medicine ·(unknown), Lasani S. Wijetunge, Mika Kinoshita, Matthew J. Shumway, Rebecca Hammond, Friso R. Postma, Christopher Brynczka, Roger Rush, Alexia M. Thomas, Richard Paylor, Stephen T. Warren, Peter W. Vanderklish, Peter C. Kind, Randall L. Carpenter, Mark F. Bear, Aileen M. Healy	191
6	The p53 transcriptional target gene wnt7b contributes to NGF-inducible neurite outgrowth in neuronal PC12 cells 2008 ·Differentiation ·Christopher Brynczka, B. Alex Merrick	14
7	Nerve Growth Factor Potentiates p53 DNA Binding but Inhibits Nitric Oxide-Induced Apoptosis in Neuronal PC12 Cells 2007 ·Neurochemical Research ·Christopher Brynczka, B. Alex Merrick	10
8	NGF-mediated transcriptional targets of p53 in PC12 neuronal differentiation 2007 ·BMC Genomics ·Christopher Brynczka, Paul Labhart, B. Alex Merrick	47

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact